Andrej Orszag

Mount Sinai Hospital. Toronto
Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications

The Minimum Frequency of Well-Day Capillary Blood Ketone Testing Needed to Predict 1-Month Diabetic Ketoacidosis Risk in Type 1 Diabetes.

The Minimum Frequency of Well-Day Capillary Blood Ketone Testing Needed to Predict 1-Month Diabetic Ketoacidosis Risk in Type 1 Diabetes.

Journal: Diabetes care
Published: May 07, 2026

Reproducibility of ACT, A simple-self-administered sCreening Tool for diabetic peripheral neuropathy.

Reproducibility of ACT, A simple-self-administered sCreening Tool for diabetic peripheral neuropathy.

Journal: Frontiers in neurology
Published: April 04, 2026

A Patient-Clinician Codesigned Infographic for Diabetic Ketoacidosis Education in Type 1 Diabetes.

A Patient-Clinician Codesigned Infographic for Diabetic Ketoacidosis Education in Type 1 Diabetes.

Journal: Canadian journal of diabetes
Published: January 28, 2026

Detectable C-Peptide and Diabetic Ketoacidosis Risk in Type 1 Diabetes.

Detectable C-Peptide and Diabetic Ketoacidosis Risk in Type 1 Diabetes.

Journal: Diabetes care
Published: January 28, 2026

Overall Diagnostic Performance of Multiple Versus Single Physical Examination Tests for the Prediction of Future Diabetic Neuropathy Risk.

Overall Diagnostic Performance of Multiple Versus Single Physical Examination Tests for the Prediction of Future Diabetic Neuropathy Risk.

Journal: Journal of the peripheral nervous system : JPNS
Published: October 31, 2025

Chronic Kidney Disease and Risk of Diabetic Ketoacidosis in Type 1 Diabetes.

Chronic Kidney Disease and Risk of Diabetic Ketoacidosis in Type 1 Diabetes.

Journal: Diabetes care
Published: September 25, 2025

Barriers to Diabetic Ketoacidosis Prevention in Adults With Type 1 Diabetes: Implications for Education and Implementation of New Monitoring Technologies.

Barriers to Diabetic Ketoacidosis Prevention in Adults With Type 1 Diabetes: Implications for Education and Implementation of New Monitoring Technologies.

Journal: Canadian journal of diabetes
Published: July 03, 2025

Longitudinal Determination of Diabetes Complications and Other Clinical Variables as Risk Factors for Diabetic Ketoacidosis in Type 1 Diabetes.

Longitudinal Determination of Diabetes Complications and Other Clinical Variables as Risk Factors for Diabetic Ketoacidosis in Type 1 Diabetes.

Journal: Diabetes care
Published: October 31, 2024

Insulin Pump Use and Diabetic Ketoacidosis Risk in Type 1 Diabetes: Secular Trends over Four Decades.

Insulin Pump Use and Diabetic Ketoacidosis Risk in Type 1 Diabetes: Secular Trends over Four Decades.

Journal: Diabetes technology & therapeutics
Published: October 10, 2024

Prognostic Implications of Diabetic Ketoacidosis in Adults on Long-term Mortality and Diabetes-Related Complications.

Prognostic Implications of Diabetic Ketoacidosis in Adults on Long-term Mortality and Diabetes-Related Complications.

Journal: Canadian journal of diabetes
Published: May 04, 2024

Empagliflozin add-on therapy to closed-loop insulin delivery in type 1 diabetes: a 2 × 2 factorial randomized crossover trial.

Empagliflozin add-on therapy to closed-loop insulin delivery in type 1 diabetes: a 2 × 2 factorial randomized crossover trial.

Journal: Nature medicine
Published: September 21, 2021

Corneal Confocal Microscopy Predicts the Development of Diabetic Neuropathy: A Longitudinal Diagnostic Multinational Consortium Study.

Corneal Confocal Microscopy Predicts the Development of Diabetic Neuropathy: A Longitudinal Diagnostic Multinational Consortium Study.

Journal: Diabetes care
Published: February 26, 2021
Showing 1-12 of 44

Last Updated: 09/26/2026